kxk121

Karol Kaltenbach, PhD

Contact Dr. Kaltenbach

1233 Locust Street
Suite 401
Philadelphia, PA 19107

(215) 955-4068

Most Recent Peer-reviewed Publications

  1. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes
  2. Buprenorphine for the treatment of the neonatal abstinence syndrome
  3. Reducing Stress Among Mothers in Drug Treatment: A Description of a Mindfulness Based Parenting Intervention
  4. Impact of Mindfulness-Based Parenting on Women in Treatment for Opioid Use Disorder
  5. Neonatal abstinence syndrome: Presentation and treatment considerations
  6. Neonatal abstinence syndrome: Presentation and treatment considerations
  7. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study
  8. Do maternal opioids reduce neonatal regional brain volumes: A pilot study
  9. Response to Wouldes and Woodward: Maternal methadone dose during pregnancy and infant clinical outcome
  10. The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations
  11. Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention
  12. Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes
  13. A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine
  14. Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression
  15. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication
  16. Buprenorphine treatment of opioid-dependent pregnant women: A comprehensive review
  17. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine
  18. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates
  19. Fetal assessment before and after dosing with buprenorphine or methadone
  20. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication